Wang Shi-Shi, Liu Wang-Hao
Department of Emergency Medicine, Huzhou Third Municipal Hospital, The Affiliated Hospital of Huzhou University, Huzhou 313000, Zhejiang Province, China.
Department of Geriatrics, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou 313000, Zhejiang Province, China.
World J Clin Cases. 2024 Jan 6;12(1):107-118. doi: 10.12998/wjcc.v12.i1.107.
Frailty is a common condition in elderly patients who receive percutaneous coronary intervention (PCI). However, how frailty affects clinical outcomes in this group is unclear.
To assess the link between frailty and the outcomes, such as in-hospital complications, post-procedural complications, and mortality, in elderly patients post-PCI.
The PubMed/MEDLINE, EMBASE, Cochrane Library, and Web of Science databases were screened for publications up to August 2023. The primary outcomes assessed were in-hospital and all-cause mortality, major adverse cardiovascular events (MACEs), and major bleeding. The Newcastle-Ottawa Scale was used for quality assessment.
Twenty-one studies with 739693 elderly patients undergoing PCI were included. Frailty was consistently associated with adverse outcomes. Frail patients had significantly higher risks of in-hospital mortality [risk ratio: 3.45, 95% confidence interval (95%CI): 1.90-6.25], all-cause mortality [hazard ratio (HR): 2.08, 95%CI: 1.78-2.43], MACEs (HR: 2.92, 95%CI: 1.85-4.60), and major bleeding (HR: 4.60, 95%CI: 2.89-7.32) compared to non-frail patients.
Frailty is a pivotal determinant in the prediction of risk of mortality, development of MACEs, and major bleeding in elderly individuals undergoing percutaneous coronary intervention.
衰弱是接受经皮冠状动脉介入治疗(PCI)的老年患者的常见状况。然而,衰弱如何影响该群体的临床结局尚不清楚。
评估老年PCI术后患者衰弱与住院并发症、术后并发症及死亡率等结局之间的关联。
检索PubMed/MEDLINE、EMBASE、Cochrane图书馆和Web of Science数据库,查找截至2023年8月的出版物。评估的主要结局为住院和全因死亡率、主要不良心血管事件(MACE)和大出血。采用纽卡斯尔-渥太华量表进行质量评估。
纳入了21项研究,共739693例接受PCI的老年患者。衰弱与不良结局始终相关。与非衰弱患者相比,衰弱患者的住院死亡率[风险比:3.45,95%置信区间(95%CI):1.90-6.25]、全因死亡率[风险比(HR):2.08,95%CI:1.78-2.43]、MACE(HR:2.92,95%CI:1.85-4.60)和大出血(HR:4.60,95%CI:2.89-7.32)风险显著更高。
衰弱是预测接受经皮冠状动脉介入治疗的老年个体死亡风险、发生MACE和大出血的关键决定因素。